BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8023249)

  • 1. [HDR or LDR in gynecological brachytherapy?].
    Prager W
    Strahlenther Onkol; 1994 Jun; 170(6):368. PubMed ID: 8023249
    [No Abstract]   [Full Text] [Related]  

  • 2. HDR versus LDR gynecological brachytherapy revisited.
    Scalliet P; Gerbaulet A; Dubray B
    Radiother Oncol; 1993 Aug; 28(2):118-26. PubMed ID: 8248552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences with interstitial HDR afterloading therapy in genital and breast cancer.
    Jacobs H
    Sonderb Strahlenther Onkol; 1988; 82():258-62. PubMed ID: 3134722
    [No Abstract]   [Full Text] [Related]  

  • 4. HDR brachytherapy with improved accuracy using anatomically adapted treatment planning.
    Ragnhult I; Himmelmann A
    Sonderb Strahlenther Onkol; 1988; 82():90-3. PubMed ID: 3134733
    [No Abstract]   [Full Text] [Related]  

  • 5. HDR versus LDR gynaecological brachytherapy revisited.
    Jones B; Tan LT; Kingston R
    Radiother Oncol; 1994 Feb; 30(2):186. PubMed ID: 8184123
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
    Herrmann T; Christen N; Alheit HD
    Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.
    Ling CC; Sahoo N; Leibel S; Anderson LL
    Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three brachytherapy gynecological intercavitary treatment planning systems.
    Concannon PJ; Mermis N; Nguyen L; Palmer MB
    Med Dosim; 2004; 29(2):115-7. PubMed ID: 15191758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Nucletron and ROCS brachytherapy treatment planning systems for LDR and HDR applications.
    Ho AK; Sibata CH; Shin KH
    Med Dosim; 1994; 19(3):147-9. PubMed ID: 7818754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
    Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDR in gynecological applications: dose and volume considerations.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1379-80; author reply 1381. PubMed ID: 2045312
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current methods in brachytherapy of female genital malignancies].
    Kanaev SV; Turkevich VG; Baranov SB
    Vopr Onkol; 1997; 43(1):47-53. PubMed ID: 9133086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavitary brachytherapy with long and short-term afterloading technic in gynecology].
    Bauer M
    Gynakologe; 1987 Dec; 20(4):228-36. PubMed ID: 3325373
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point: why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?
    Davidson SE; Hendry JH; West CM
    Brachytherapy; 2009; 8(3):269-72. PubMed ID: 19643373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.